Edition:
United States

Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

8.20USD
3:59pm EST
Change (% chg)

$-0.30 (-3.53%)
Prev Close
$8.50
Open
$8.50
Day's High
$8.55
Day's Low
$8.15
Volume
80,735
Avg. Vol
62,117
52-wk High
$13.70
52-wk Low
$7.33

ZGNX.OQ

Chart for ZGNX.OQ

About

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders in requirement of treatment alternatives. The Company's areas of focus are epilepsy and schizophrenia. Its lead... (more)

Overall

Beta: 1.53
Market Cap(Mil.): $210.72
Shares Outstanding(Mil.): 24.79
Dividend: --
Yield (%): --

Financials

  ZGNX.OQ Industry Sector
P/E (TTM): -- 44.03 29.85
EPS (TTM): -2.30 -- --
ROI: -21.56 -1.39 14.85
ROE: -34.33 -1.05 16.28

BRIEF-Zogenix Q3 revenue $6.6 mln

* Research and development expenses are now expected to be $42-44 million for full year 2016

Nov 07 2016

BRIEF-Zogenix amends manufacturing services agreement

* Zogenix Inc Co, Patheon UK limited entered into amendment to the manufacturing services agreement, dated February 28, 2013

Aug 26 2016

BRIEF-Zogenix Q2 loss per share $0.76

* Zogenix provides corporate update and reports second quarter 2016 financial results

Aug 09 2016

Earnings vs. Estimates